PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Company ReportsJazz Pharmaceuticals
Jazz Pharmaceuticals(JAZZ)
Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a biopharmaceutical company based in Ireland. It was founded in 2003. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem (sodium oxybate), the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
DefitelioDefibrotide2016-03-302032
ErwinazeAsparaginase erwinia chrysanthemi2011-11-18
FazacloClozapine2004-02-102028
LuvoxFluvoxamine2008-02-28
RylazeAsparaginase erwinia chrysanthemi (recombinant)2021-06-30
Vyxeos (previously vyxeos)Cytarabine, Daunorubicin2018-08-232025-2032
XyremOxybate2002-07-172024-2042
XywavMagnesium oxybate, Oxybate, Potassium oxybate2020-07-212024-2042
ZepzelcaLurbinectedin2020-06-152029
EpidyolexCannabidiol2019-09-192035-2041
EnrylazeCrisantaspase2023-09-15
EpidiolexCannabidiol2018-09-282035-2041
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lurbinectedin
Cannabidiol
Cytarabine
Benzocaine
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use